Auxilium and introduce Prasco authorized generic version of Testim -
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated biopharmaceutical company, today announced that it has partnered with Prasco, LLC ( "Prasco") to introduce an authorized generic version of Testim ® (testosterone gel). Prasco has product inventory available and began shipping products. Testim and its authorized generic version of testosterone gels are approved by the Food and Drug Administration of the United States to treat adult men with little or no testosterone.
"While Testim continued to represent a significant share of total Auxilium business, we have been proactively planning for the launch in an effort to strategically position our franchise more products to compete in the testosterone replacement therapy gel market increasingly crowded and difficult (TRT), "said Adrian Adams, CEO and President of Auxilium. "We believe the launch of the authorized generic of Testim with Prasco could expand the franchise market Testim, build on our efforts to manage Testim as a mature brand and allow Auxilium to achieve maximum value for shareholders."
Auxilium will maintain responsibility for the manufacture of generic and Testim testosterone gel approved and for the distribution of the Testim brand.
EmoticonEmoticon